Randomized Controlled Trial
doi: 10.1001/jamapsychiatry.2023.4680.
Psilocybin in Bipolar II Study Provides Preliminary Data on Safety
Affiliations
- PMID: 38055240
- DOI: 10.1001/jamapsychiatry.2023.4680
Item in Clipboard
Randomized Controlled Trial
Psilocybin in Bipolar II Study Provides Preliminary Data on Safety
JAMA Psychiatry.
.
No abstract available
Comment in
-
Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial.JAMA Psychiatry. 2024 Jun 1;81(6):555-562. doi: 10.1001/jamapsychiatry.2023.4685. JAMA Psychiatry. 2024. PMID: 38055270 Free PMC article. Clinical Trial.
Similar articles
-
Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety.JAMA Psychiatry. 2024 Jun 1;81(6):633-634. doi: 10.1001/jamapsychiatry.2024.0420. JAMA Psychiatry. 2024. PMID: 38598200 No abstract available.
-
Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety-Reply.JAMA Psychiatry. 2024 Jun 1;81(6):634. doi: 10.1001/jamapsychiatry.2024.0423. JAMA Psychiatry. 2024. PMID: 38598225 No abstract available.
-
Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial.JAMA Psychiatry. 2024 Jun 1;81(6):555-562. doi: 10.1001/jamapsychiatry.2023.4685. JAMA Psychiatry. 2024. PMID: 38055270 Free PMC article. Clinical Trial.
-
Psilocybin--summary of knowledge and new perspectives.Eur Neuropsychopharmacol. 2014 Mar;24(3):342-56. doi: 10.1016/j.euroneuro.2013.12.006. Epub 2013 Dec 17. Eur Neuropsychopharmacol. 2014. PMID: 24444771 Review.
-
The pharmacology of psilocybin.Addict Biol. 2002 Oct;7(4):357-64. doi: 10.1080/1355621021000005937. Addict Biol. 2002. PMID: 14578010 Review.
